$CLAR SEC Filings

Filed On	Filing
01 Oct 2026	SCHEDULE 13D/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
01 Jun 2026	Form 4: Werner Roger, Director Granted 20,000 Stock Option (right to purchase)
01 Jun 2026	Form 4: Sokolow Nicolas, Director Granted 20,000 Stock Option (right to purchase)
01 Jun 2026	Form 4: Ottmann Susan, Director Granted 20,000 Stock Option (right to purchase)
01 Jun 2026	Form 4: Besca Mark, Director Granted 20,000 Stock Option (right to purchase)
01 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
29 May 2026	FORM SD
15 May 2026	SCHEDULE 13G/A
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition
24 Apr 2026	ARS
24 Apr 2026	Proxy statement: annual meeting on May 28, 2026 say-on-pay vote
17 Apr 2026	SCHEDULE 13G/A
11 Mar 2026	Form 4: Yates Michael J, Chief Financial Officer Received 25,000 shares by exercise or conversion
05 Mar 2026	10-K
05 Mar 2026	8-K: Results of Operations and Financial Condition
06 Nov 2025	10-Q
06 Nov 2025	8-K: Results of Operations and Financial Condition

Comments